Financials

  • Market Capitalization 752.63 M
  • Employee 92
  • Founded 2011
  • CEO N/A
  • Website www.annexonbio.com
  • Headquarter Delaware, United States
  • FIGI BBG007QVDFG2
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.75
Relación precio/flujo de caja
—

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2563
GYRE
Gyre Therapeutics, Inc. - Common Stock
6.96 USD-1.14%-4.26%+2.05%-15.74%776.11 M USD
2567
VSTM
Verastem, Inc. - Common Stock
8.28 USD-1.19%+4.81%+12.50%-4.28%749.87 M USD
2581
CADL
Candel Therapeutics, Inc. - Common Stock
9.85 USD-0.91%-4.83%-5.38%+56.85%753.71 M USD
2582
ACHV
Achieve Life Sciences, Inc. - Common Shares
7.11 USD-4.05%+1.72%+0.71%+127.88%731.64 M USD

Noticias